Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients (Q35898302)

11 August 2017

Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients (English)

1 reference

11 August 2017

1 reference

1 reference

Donna M Lehman

1

1 reference

11 August 2017

Carlos Lorenzo

series ordinal

2

1 reference

11 August 2017

Javier Hernandez

series ordinal

3

1 reference

11 August 2017

Chen-Pin Wang

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

28 March 2012

1 reference

11 August 2017

1 reference

11 August 2017

35

1 reference

11 August 2017

1002-1007

1 reference

11 August 2017

5

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

11 August 2017

start time

1 September 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Body fatness and sex steroid hormone concentrations in US men: results from NHANES III.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Statins and prostate cancer diagnosis and grade in a veterans population

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Metformin in prostate cancer: two for the price of one.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Statins and prostate cancer: molecular and clinical aspects

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Metabolic alterations and targeted therapies in prostate cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Review of recent evidence in support of a role for statins in the prevention of prostate cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Do the cholesterol-lowering properties of statins affect cancer risk?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Cholesterol and prostate cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Role of AMP-activated protein kinase in mechanism of metformin action

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

An overview of metformin in the treatment of type 2 diabetes mellitus

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Initiation of insulin among veterans with type 2 diabetes and sustained elevation of A1c.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329836

The Risk of Cancer in Users of Statins

24 September 2018

1 reference

12 December 2020

Do statins protect against prostate cancer?

1 reference

12 December 2020

Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer

1 reference

12 December 2020

Metformin and the incidence of prostate cancer in patients with type 2 diabetes

1 reference

12 December 2020

Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?

1 reference

12 December 2020

Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study

1 reference

12 December 2020

A meta-analysis of diabetes mellitus and the risk of prostate cancer

1 reference

12 December 2020

The blooming of the French lilac

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI14178

Identifiers

DOI

10.2337/DC11-1829

1 reference

release_utzdkmlgzrghhmcpmg6vdfuotq

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/utzdkmlgzrghhmcpmg6vdfuotq

24 November 2022

mapped directly with Wikidata item

1 reference

11 August 2017

1 reference